SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice. (Q37575455)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice. |
scientific article |
Statements
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice (English)
Maria Gerasimova
Michael A Rose
Joseph Satriano
Eric Mayoux
Hermann Koepsell
Scott C Thomson
13 November 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference